Paranovus Entertainment Technology Ltd (PAVS) FinancialsPAVSParanovus Entertainment Technology Ltd

Paranovus Entertainment Technology Ltd. (PAVS) generates its revenue through a diversified portfolio of business segments. Currently, the largest contributor to its top-line growth is Lucidum spore powder products, accounting for 51.3% of total sales, equivalent to $17.28M. Other significant revenue streams include Others and Cordyceps mycelia products. Understanding this composition is critical for investors evaluating how PAVS navigates market cycles within the Software industry.

Evaluating the bottom line, Paranovus Entertainment Technology Ltd. maintains a gross margin of 19.98%. This metric reflects the company's pricing power and manufacturing efficiency. Further down the income statement, the operating margin stands at -5.06%, while the net margin is -4.70%. These profitability ratios, combined with a Return on Equity (ROE) of -23.85%, provide a clear picture of how effectively PAVS converts its operational activities into shareholder value.

In the context of the broader market, PAVS competes directly with industry leaders such as ATPC and PMCB. With a market capitalization of $2.49M, it holds a significant position in the sector. When comparing efficiency, PAVS's gross margin of 19.98% stands against ATPC's 85.96% and PMCB's N/A. Such benchmarking helps identify whether Paranovus Entertainment Technology Ltd. is trading at a premium or discount relative to its financial performance.

The company has shown a total revenue of $3,088 in Q1 2026, but it has a net income loss of -$5,708,306, indicating significant financial challenges. The gross margin is also negative at -6161.27%, reflecting poor profitability.